Neuroscientific Biopharmaceuticals (ASX:NSB) Receivables Turnover : 0.00 (As of Dec. 2024)

Neuroscientific Biopharmaceuticals Receivables Turnover Chart

Neuroscientific Biopharmaceuticals Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Receivables Turnover	Get a 7-Day Free Trial								12.40	-	-	-	-

Competitive Comparison of Neuroscientific Biopharmaceuticals's Receivables Turnover

For the Biotechnology subindustry, Neuroscientific Biopharmaceuticals's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Neuroscientific Biopharmaceuticals's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Neuroscientific Biopharmaceuticals's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Neuroscientific Biopharmaceuticals's Receivables Turnover falls into.

Neuroscientific Biopharmaceuticals Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Neuroscientific Biopharmaceuticals's Receivables Turnover for the fiscal year that ended in Jun. 2024 is calculated as

Neuroscientific Biopharmaceuticals's Receivables Turnover for the quarter that ended in Dec. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neuroscientific Biopharmaceuticals  (ASX:NSB) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Neuroscientific Biopharmaceuticals Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Neuroscientific Biopharmaceuticals's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Neuroscientific Biopharmaceuticals Business Description